Stada Delays Annual Meeting as Activist Battle EscalatesBy
Stada postpones shareholder meeting scheduled for June 9
Company brings forward by two years process to renew board
Stada Arzneimittel AG, the German generic-drug maker targeted by shareholder activist Active Ownership Capital Sarl, postponed its annual general meeting scheduled for June 9, striking back at attempts to impose swift change on the supervisory board.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.